← All organizations

China Immunotech

China Immunotech

For profitWebsite ↗

Also known as: China Immunotech (Beijing) Biotechnology Co., Ltd. | China Immunotech Co., Ltd. | China Immunotech Pharmaceuticals Co.Ltd.

Phase 1 Phase 2 Phase 3 Phase 4

Highest phase reached

Phase 2

First clinical trial

Last known activity

Jun 15, 2023

Timeline

2010s

Jan 1, 2018
China Immunotech— Founded

Drugs by trial phase (8 distinct, 11 trials)

Phase 2 (1 own, 0 via acquisition)

autologous ebv specific cytotoxic t lymphocytes

Phase 1 (7 own, 0 via acquisition)

Indications

Studied for

Recent trials (11)

NCT05913804CollaboratorPhase 1Jun 15, 2023
NCT04697290CollaboratorEarly Phase 1Mar 10, 2021
NCT04506983CollaboratorPhase 1Aug 10, 2020
NCT04508842CollaboratorPhase 1Aug 10, 2020
NCT04260945CollaboratorPhase 1Feb 10, 2020
NCT04260932CollaboratorPhase 1Feb 10, 2020
NCT04153279CollaboratorPhase 1Dec 1, 2019
NCT04156217CollaboratorPhase 1Dec 1, 2019
NCT03953599CollaboratorPhase 1Jul 1, 2019
NCT03952923CollaboratorPhase 1Jul 1, 2019
NCT03648697CollaboratorPhase 2Oct 10, 2018

Details

Founded: Beijing, CN Jan 1, 2018
Last known activity: Jun 15, 2023